Health Condition 1: N970- Female infertility associated withanovulation
Conditions
Interventions
None listed
Sponsors
Dr Anshika Goel
Eligibility
Inclusion criteria
Inclusion criteria: All cases of primary or secondary infertility confirmed with anovulation on folliculometry Married Female patients of the age group 21 to 35 years One fallopian tube must be patent Male counterpart should be normal in all aspects Patients willing to participate in this trial through written informed consent
Exclusion criteria
Exclusion criteria: Congenital anatomical defects of reproductive tract like Bicornuate uterus etc Pathologies as Cervical Stenosis,Malignancy etc Infertility due to peritoneal factors,uterine factors and cervical factors Patient suffering from diseases such as Diabetes Mellitus,Hypertension ,Hypothyroidism, Hyperthyroidism,Tuberculosis,Renal disorder etc Patient taking Hormonal therapy from last 3 months or any other treatment Bilateral tubal blockage Infertility due to abnormality in male partner
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Follicles getting rupture as seen in USGTimepoint: 3 months The drug trial will be given for 3 days for 3 consecutive menstrual cycle after the cessation of menses | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement in menstrual cycle parameters Dominant follicle size Endometrial thickness Conception rateTimepoint: After analyzing all the parameters the result will be assessed on the basis of symptomatic relief and improvement. Partially improvement After 1 month-patient get 40-60 percent relief from sign and symptoms Improvement After 2 month patient get 60-80 percent relief from sign and symptoms Cured after 3 months-patient get 80-100 percent relief from sign and symptoms. | — |
Countries
India
Contacts
Public ContactDr Bhappil Sharma
Vaidya Yagya Dutt Sharma Ayurved Mahavidyalaya Khurja
Outcome results
None listed